MicroRNA‐483 amelioration of experimental pulmonary hypertension

MicroRNA‐483 amelioration of experimental pulmonary hypertension

Abstract Endothelial dysfunction is critically involved in the pathogenesis of pulmonary arterial hypertension (PAH) and that exogenously administered microRNA may be of therapeutic benefit. Lower levels of miR‐483 were found in serum from patients with idiopathic pulmonary arterial hypertension (IP...

Full description

Bibliographic Details
Main Authors: Jin Zhang, Yangyang He, Xiaosong Yan, Shanshan Chen, Ming He, Yuyang Lei, Jiao Zhang, Brendan Gongol, Mingxia Gu, Yifei Miao, Liang Bai, Xiaopei Cui, Xiaojian Wang, Yixin Zhang, Fenling Fan, Zhao Li, Yuan Shen, Chih‐Hung Chou, Hsien‐Da Huang, Atul Malhotra, Marlene Rabinovitch, Zhi‐Cheng Jing, John Y‐J Shyy
Format: Article
Language:English
Published: Springer Nature 2020-04-01
Series:EMBO Molecular Medicine
Subjects:
miR‐483
endothelium
pulmonary hypertension
TGF‐β
Online Access:https://doi.org/10.15252/emmm.201911303

Internet

https://doi.org/10.15252/emmm.201911303

Similar Items